FT.com / Search

1-10 of 465,755 results for In re: Guidant Corp Implantable Defibrillators Products Liability Litigation

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

January 24, 2006
J&J reveals its Guidant motive
...analysts at a restaurant in midtown Manhattan on Tuesday night. Guidant’s directors left...would be seen J&J covets Guidant’s implantable defibrillators, pacemakers and stents...expected positive trends in its existing medical...declined to comment on the Guidant negotiations. Last year... By Christopher Bowe and James Politi in New York
November 7, 2005
Guidant sues J&J over acquisition price
...deaths. Overall, sales at Guidant fell 14 per cent to $795m in the quarter. Sales of implantable defibrillators – one of Guidant’s key products – dropped 26 per cent to...a further 3.9 per cent in morning trading. Guidant... By James Politi in New York
January 25, 2006
J&J reveals its Guidant motive
...midtown Manhattan yesterday evening. Guidant's directors left waiting to hear...earnings growth would be seen as failure in terms of the company's traditional yardsticks. J&J covets Guidant's implantable defibrillators, pacemakers and stents to boost its...J said it expected positive trends in its existing medical-device business... By Christopher Bowe and James Politi in New York
January 25, 2006
J&J reveals its Guidant motive
...initially agreed terms with J&J, Guidant's board deems Boston's offer...earnings growth would be seen as failure in terms of the company's traditional yardsticks. J&J covets Guidant's implantable defibrillators, pacemakers and stents to boost its...J said it expected positive trends in its existing medical-device business... By Christopher Bowe in New York
January 18, 2006
Rivals in Guidant fight monitor its potential
...J&J and Boston's interest. But Guidant also has significant expertise in stents, tiny props used to open closing...arteries. Both J&J and Boston covet Guidant's products as an addition to their own important business in stents. Implantable devices to treat weakening, or sudden... By Christopher Bowe in New York
January 17, 2006
Rivals in Guidant fight monitor its potential
...J and Boston’s interest. But Guidant also has significant expertise in stents, tiny props used to open closing...arteries. Both J&J and Boston covet Guidant’s products as an addition to their own important business in stents. Implantable devices to treat weakening, or sudden... By Christopher Bowe in New York
January 12, 2006
J&J raises offer to $23.2bn in Guidant bid war
...Together with Guidant, we have spent more...problems emerged in June for Guidant. After several months...including pacemakers and implantable cardioverter defibrillators. ICDs, devices...proper rhythm, are Guidant’s most important products and crucial to its...over Guidant are its implantable heart devices, particularly...Guidant is number two in this market, which... By James Politi in New York
July 18, 2005
Guidant in further warning on heart devices
...worldwide. The news sent shares of Guidant down 1.3 per cent to $68.46 in mid-day trade on Monday, adding to speculation that J&J may re-examine the deal and lower the price of $76 per share agreed in December. Shares in J&J edged...on Monday. J&J is attracted to Guidant by the growth and high margins in its implantable heart devices business. The deal...a supermarket of medical device products including orthopaedic implants and...first recall of implantable cardiac defibrillators on June 17, shares in Guidant have... By Amy Yee in New York
August 17, 2005
J&J set to get Guidant approval
...with J&J and Boston Scientific. Guidant's heart rhythm devices are the key prize in the deal. Pacemakers and implantable defibrillators, which keep hearts beating in correct rhythm and shock them to...aberrations, account for most of Guidant's roughly $4bn annual sales...the recalls have put Guidant's products at a competitive disadvantage. This... By Tobias Buck in Brussels and Christopher Bowe in New York
November 8, 2005
Guidant files lawsuit over $25bn deal
...deaths. Overall, sales at Guidant fell 14 per cent to $795m in the quarter. Sales of implantable defibrillators - one of Guidant's key products - dropped 26 per cent to...a further 3.9 per cent in morning trading. Guidant... By James Politi in New York